AI Robots Name | P/L | Entry Price, $ | Profit, $/% |
---|
AI Robots Name | P/L | Entry Price, $ | Profit, $/% |
---|
The Moving Average Convergence Divergence (MACD) for ADPT turned positive on March 24, 2023. Looking at past instances where ADPT's MACD turned positive, the stock continued to rise in 29 of 31 cases over the following month. The odds of a continued upward trend are 90%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 46 cases where ADPT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on March 24, 2023. You may want to consider a long position or call options on ADPT as a result. In of 64 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ADPT advanced for three days, in of 225 cases, the price rose further within the following month. The odds of a continued upward trend are .
ADPT moved below its 50-day moving average on March 09, 2023 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ADPT crossed bearishly below the 50-day moving average on March 02, 2023. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADPT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for ADPT entered a downward trend on March 21, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ADPT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.691) is normal, around the industry mean (21.930). P/E Ratio (0.000) is within average values for comparable stocks, (123.806). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.812). Dividend Yield (0.000) settles around the average of (0.028) among similar stocks. P/S Ratio (6.707) is also within normal values, averaging (302.440).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ADPT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a company, which engages in the development of an immune medicine platform
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LKINX | 11.93 | 0.10 | +0.85% |
LKCM International Equity | |||
FRBSX | 30.64 | 0.21 | +0.69% |
Franklin Mutual U.S. Mid Cap Value A | |||
PXEAX | 20.31 | 0.11 | +0.54% |
Impax Global Environmental Markets A | |||
MTILX | 11.76 | 0.04 | +0.34% |
Morgan Stanley Inst Glbl Infras L | |||
MINRX | 32.96 | 0.08 | +0.24% |
MFS International Intrinsic Value R1 |
A.I.dvisor indicates that over the last year, ADPT has been closely correlated with VCYT. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if ADPT jumps, then VCYT could also see price increases.
Ticker / NAME | Correlation To ADPT | 1D Price Change % |
---|---|---|
ADPT | 100% | +3.44% |
VCYT - ADPT | 71% Closely correlated | -0.27% |
BEAM - ADPT | 69% Closely correlated | +0.49% |
EDIT - ADPT | 68% Closely correlated | -0.13% |
OCGN - ADPT | 67% Closely correlated | -3.96% |
QSI - ADPT | 65% Loosely correlated | +3.12% |
More |